Brisbane, CA, United States of America

Melissa Fleury

USPTO Granted Patents = 92 

 

 

Average Co-Inventor Count = 3.8

ph-index = 16

Forward Citations = 869(Granted Patents)

Forward Citations (Not Self Cited) = 173(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • San Mateo, CA (US) (2012)
  • San Francisco, CA (US) (2011 - 2017)
  • Brisbane, CA (US) (2015 - 2024)

Company Filing History:


Years Active: 2011-2025

Loading Chart...
Loading Chart...
Loading Chart...
Areas of Expertise:
JAK Kinase Inhibitors
Neprilysin Inhibitors
Muscarinic Receptor Antagonists
Beta2 Adrenergic Receptor Agonists
Pyrimidine Compounds
Crystalline Compounds
Respiratory Disease Treatments
Diamide Compounds
92 patents (USPTO):Explore Patents

As an AI assistant specializing in innovations, inventions, inventors, patent attorneys, and patents, I am here to assist you.

Title: Melissa Fleury: Pioneering Inventor in Neprilysin Inhibitors

Introduction:

Melissa Fleury, a brilliant inventor based in Brisbane, CA, has made significant strides in the field of pharmaceuticals. With a remarkable portfolio of 89 patents, Melissa is known for her groundbreaking work in neprilysin inhibitors.

Latest Patents:

In her latest patents, Melissa has introduced compounds with formulas aimed at neprilysin inhibition activity. These compounds, along with their pharmaceutical compositions, are paving the way for innovative treatment methods and processes in the medical industry.

Career Highlights:

Melissa's career highlights include her tenure at Theravance Biopharma R&D IP, LLC, and Theravance, Inc. Her expertise and dedication have been instrumental in the development of cutting-edge pharmaceutical solutions that have the potential to revolutionize the treatment of various medical conditions.

Collaborations:

Throughout her career, Melissa has collaborated with esteemed professionals in the field, including coworkers such as Adam D Hughes and Roland Gendron. These collaborations have led to a synergistic approach to innovation, resulting in the successful implementation of new ideas and technologies.

Conclusion:

In conclusion, Melissa Fleury stands out as a trailblazing inventor in the realm of neprilysin inhibitors. Her passion for innovation, coupled with her exceptional talent, has positioned her as a key figure in driving advancements in the pharmaceutical industry. Melissa's continued dedication to pushing boundaries and creating solutions underscores her importance in shaping the future of healthcare.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…